Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Magnesium aluminum hydroxide is a combination antacid consisting of magnesium hydroxide and aluminum hydroxide. In the clinical research context of Isfahan University of Medical Sciences, it is utilized as a topical oral rinse, often as a primary component of a "magic mouthwash" formulation, for the management of cancer treatment-induced stomatitis (oral mucositis). Its therapeutic effect in this setting is primarily attributed to its role as a mucosal protective agent; it provides a physical coating over the oral mucosa that protects ulcerated tissues and exposed nerve endings from chemical and mechanical irritation, thereby reducing pain. While its systemic use is intended for the neutralization of gastric acid, its topical application in the oral cavity leverages its soothing and barrier-forming properties to alleviate the symptoms of severe mucositis in patients undergoing head and neck cancer therapy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on magnesium hydroxide + aluminum hydroxide.